FundaMeric-BernstamMD

PubMed

• Precision Oncology in Hepatopancreatobiliary Cancer Surgery.
  Newhook, T., Meric-Bernstam, F., Tsai, S.> ;Surgical Oncology Clinics of North America. 2024 Apr 1
• RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.
  Jason Roszik, Carmelia Maria Noia Barretto, Erick Campbell, Amber M Johnson, Isabella C Glitza Oliva, Blessie Elizabeth Nelson, Jibran Ahmed, Mirella Nardo, Sarina A P...> ;Molecular Cancer. 2024 Mar 26
• Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan.
  Toshio Shimizu, Noboru Yamamoto, Takahiro Kogawa, Francesca Pisetzky, Priyanka Basak, Cindy Lau, Rebecca S Heist, Jacob Sands, Aditya Bardia, Aaron Lisberg, Ian Krop, ...> ;Cancer Treatment Reviews. 2024 Apr 1
• Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer.
  Gouda, M., Iorgulescu, J., Shen, T., Wu, J., Subbiah, V., Dadu, R., Patel, K., Sherman, S., Cabanillas, M., Hu, M., Castellanos, L., Amini, B., Meric-Bernstam, F.> ;NPJ Precision Oncology. 2024 Mar 4
• Ataxia-Telangiectasia Mutated (ATM) loss of function displays variant and tissue-specific differences across tumor types.
  Pilie, P., Giuliani, V., Wang, W., McGrail, D., Bristow, C., Ngoi, N., Kyewalabye, K., Wani, K., Le, H., Campbell, E., Sánchez, N., Yang, D., Gheeya, J., Goswamy, R., ...> ;Clinical Cancer Research. 2024 Feb 28
• Co-Clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts.
  DiPeri, T., Evans, K., Wang, B., Zhao, M., Akcakanat, A., Raso, M., Rizvi, Y., Zheng, X., Korkut, A., Varadarajan, K., Uzunparmak, B., Dumbrava, E., Pant, S., Ajani, J...> ;Cancer Discovery. 2024 Feb 15
• Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid M...
  Subbiah, V., Coleman, N., Piha-Paul, S., Tsimberidou, A., Janku, F., Rodon, J., Pant, S., Dumbrava, E., Fu, S., Hong, D., Zhang, S., Sun, M., Jiang, Y., Roszik, J., So...> ;Cancer Research Communications. 2024 Feb 12
• Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer.
  Qiao, N., Guerriero, J., Gross, B., Meneksedag, Y., Lu, Y., Philips, A., Roszik, J., Chen, K., Peoples, G., Alatrash, G., Goldberg, J., Rahman, T., Meric-Bernstam, F.,...> ;Cancer Research Communications. 2024 Feb 22
• Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients.
  Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do-Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal> ;Clinical Cancer Research. 2024 Apr 15
• Limited Independent Follow-Up with Germline Testing of Variants Detected inandby Tumor-Only Sequencing.
  Nowlen, C., Daniels, M., Uzunparmak, B., Ileana Dumbrava, E., Yuan, Y., Patel, K., Rayes, N., Harkenrider, J., Wathoo, C., Veazie, J., Luna, K., Wang, W., Horombe, C.,...> ;Journal of Immunotherapy and Precision Oncology. 2024 Feb 1
• Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
  Coleman, N., Stephen, B., Ahnert, J., Wright, J., Fessahaye, S., Ouyang, F., Yilmaz, B., Fu, S., Karp, D., Subbiah, V., Piha-Paul, S., Meric-Bernstam, F., Naing, A.> ;Cancer Medicine. 2024 Feb 1
• ASO Visual Abstract: Defining the Biology of Estrogen Receptor-Low Positive Breast Cancer.
  Higgins, T., Harrison, B., Giordano, J., McGrath, M., Kantor, O., Burstein, H., Schnitt, S., Rahman, T., Vora, H., Garrido-Castro, A., Tolaney, S., Meric-Bernstam, F.,...> ;Annals of Surgical Oncology. 2024 Apr 1
• ASO Visual Abstract: Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer.
  Woodfin, A., Yam, C., Teshome, M., Kuerer, H., Hunt, K., Meric-Bernstam, F., Schaverien, M., Barcenas, C., Sun, S.> ;Annals of Surgical Oncology. 2024 Apr 1
• 1 citations
  Defining the Biology of Estrogen Receptor-Low-Positive Breast Cancer.
  Higgins, T., Harrison, B., Giordano, J., McGrath, M., Kantor, O., Burstein, H., Schnitt, S., Rahman, T., Vora, H., Garrido-Castro, A., Tolaney, S., Meric-Bernstam, F.,...> ;Annals of Surgical Oncology. 2024 Apr 1
• Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carc...
  Lim, K., Yige Wu, Siqi Chen, Xiaolu Yang, Kazuhito Sato, Preet Lal, Yuefan Wang, Andrew T Shinkle, Michael C Wendl, Tina M Primeau, Yanyan Zhao, Alanna Gould, Hua Sun,...> ;Cancer Research. 2023 Dec 15
• Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer.
  Turcin Saridogan, Argun Akcakanat, Ming Zhao, Kurt W Evans, Erkan Yuca, Stephen Scott, Bryce P Kirby, Xiaofeng Zheng, Min Jin Ha, Huiqin Chen, Patrick K S Ng, Timothy ...> ;Scientific Reports. 2023 Nov 18
• Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer.
  Ashley A Woodfin, Clinton Yam, Mediget Teshome, Henry M Kuerer, Kelly K Hunt, Funda Meric-Bernstam, Mark Schaverien, Carlos H Barcenas, Susie X Sun> ;Annals of Surgical Oncology. 2024 Feb 1
• 1 citations
  Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma.
  DiPeri, T., Zhao, M., Evans, K., Varadarajan, K., Moss, T., Scott, S., Kahle, M., Byrnes, C., Chen, H., Lee, S., Halim, A., Hirai, H., Wacheck, V., Kwong, L., Rodon, J...> ;Journal of Hepatology. 2024 Feb 1
• 17 citations
  Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial.
  Funda Meric-Bernstam, Vicky Makker, Ana Oaknin, Do-Youn Oh, Susana Banerjee, Antonio González-Martín, Kyung Hae Jung, Iwona Ługowska, Luis Manso, Aránzazu Manzano, Boh...> ;Journal of Clinical Oncology. 2024 Jan 1
• Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.
  Anne Knisely, Jibran Ahmed, Bettzy Stephen, Sarina A Piha-Paul, Daniel Karp, Abdulrazzak Zarifa, Siqing Fu, David Sanghyun Hong, Jordi Rodon Ahnert, Timothy A Yap, Apo...> ;Cancer. 2024 Feb 1
• 3 citations
  Molecular tumour boards - current and future considerations for precision oncology.
  Apostolia M Tsimberidou, Michael Kahle, Henry Hiep Vo, Mehmet A Baysal, Amber Johnson, Funda Meric-Bernstam> ;Nature Reviews. Clinical Oncology. 2023 Dec 1
• 2 citations
  MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth...
  Christopher J Sweeney, John D Hainsworth, Ron Bose, Howard A Burris, Razelle Kurzrock, Charles Swanton, Claire F Friedman, David R Spigel, Tania Szado, Katja Schulze, ...> ;Journal of Clinical Oncology. 2024 Jan 20
• Leveraging TROP2 Antibody-Drug Conjugates in Solid Tumors.
  Blessie Elizabeth Nelson, Funda Meric-Bernstam> ;Annual Review of Medicine. 2024 Jan 29
• 1 citations
  To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast C...
  Clara Farley, Roland Bassett, Funda Meric-Bernstam, Isabelle Bedrosian, Abigail Caudle, Sarah DeSnyder, Kelly Hunt, Henry Kuerer, Puneet Singh, Susie Sun, Nina Tamiris...> ;Annals of Surgical Oncology. 2023 Dec 1
• Nivolumab Plus Ipilimumab in Patients With Solid Tumors WithMutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
  Rohatgi, N., Rothe, M., Mangat, P., Garrett-Mayer, E., Meric-Bernstam, F., Pisick, E., Alese, O., Reynolds, C., Thota, R., Vaccaro, G., von Mehren, M., Arend, R., Chiu...> ;JCO Precision Oncology. 2023 Sep 1
• Join now to see all

Lectures

• Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas. 
  2019 ASCO Annual Meeting - 6/1/2019
• Preliminary Results of the Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Two Phase IIa Dose Expansion Cohorts in Relapsed/Refractory TP53 Wild-Type ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Single agent activity of ZW25, a HER's targeted bispecific antibody, in heavily pretreated HERs' expressing cancers. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
• Symposia on Cancer Research 2013 
  The University of Texas, M. D. Anderson Cancer Center, Houston, Texas - 10/4/2013
• Symposia on Cancer Research 2013 
  The University of Texas, M. D. Anderson Cancer Center, Houston, Texas - 10/4/2013
• Somatic Mutation Testing and Opportunities for Clinical Interventions 
  Houston, TX - 10/28/2014
• Join now to see all